Role of enolase-1 in response to hypoxia in breast cancer: Exploring the mechanisms of action
Authors:
Open Access
- 1 February 2013
- journal article
- Published by Spandidos Publications in Oncology Reports
- Vol. 29 (4) , 1322-1332
Abstract
In the present study, we investigated the effect of reduced enolase-1 expression in human umbilical vein endothelial cells (HUVECs)/MDA-MB-231 cells on the response to hypoxia and the possible mechanisms involved. Breast cancer cells transfected with enolase-1 siRNA were injected into mice to establish a tumor-bearing mouse model, and the correlation between enolase-1 expression and breast cancer angiogenesis, as well as its effect on the efficacy of radiation therapy were assessed. HUVECs were cultured in vitro, and transfected with enolase-1 siRNA. Following stable passage, 1.0% O2 was used to induce hypoxia. The growth, proliferation, division and angiogenesis of HUVECs were observed using MTT assay, flow cytometry (FCM) and time-lapse video microscopy. The key regulatory molecules were detected using western blot analysis, two-dimensional (2-D) electrophoresis and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS). The breast cancer cell line, MDA-MB-231, was cultured in vitro, and transfected with enolase-1 siRNA. The cells were injected into nude mice, and radiation therapy was administered. Tumor growth, angiogenesis in tumor tissues and apoptosis were observed, and the expression of the endogenous hypoxia marker, hypoxia inducible factor-1α (HIF-1α), was detected using immunohistochemistry after the mice were sacrificed. A significant reduction in the hypoxia-induced apoptosis of HUVECs was observed in the control group compared with the endothelial cells transfected with enolase-1 siRNA. After the enolase-1 transfected breast cancer cells were injected into nude mice, tumor growth significantly declined, and the tumor volume and weight were reduced. Following treatment with radiation therapy, tumor size significantly decreased in both groups, and the highest reduction was observed in the transfected group. The reduction in enolase-1 expression significantly decreases the response to hypoxia and enhances the sensitivity of the cells to radiation therapy; therefore, enolase-1 may be a drug target for the treatment of breast cancer.Keywords
This publication has 26 references indexed in Scilit:
- In vitro reoxygenation following hypoxia increases MMP-2 and TIMP-2 secretion by human umbilical vein endothelial cells.Acta Biochimica Polonica, 2010
- Hypoxia-inducible factors: central regulators of the tumor phenotypeCurrent Opinion in Genetics & Development, 2007
- Proteomic analysis of isolated membrane fractions from superinvasive cancer cellsBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2006
- Proteomic Study Reveals That Proteins Involved in Metabolic and Detoxification Pathways Are Highly Expressed in HER-2/neu-positive Breast CancerMolecular & Cellular Proteomics, 2005
- Bcl-xL-Mediated Changes in Metabolic Pathways of Breast Cancer CellsThe American Journal of Pathology, 2005
- Proteomic analysis of carbonylated proteins in two‐dimensional gel electrophoresis using avidin‐fluorescein affinity stainingElectrophoresis, 2004
- Antiapoptotic action of hypoxia-inducible factor-1α in human endothelial cellsLaboratory Investigation, 2004
- High‐throughput proteomic analysis of human infiltrating ductal carcinoma of the breastProteomics, 2003
- Cytokines induce HIF-1 DNA binding and the expression of HIF-1-dependent genes in cultured rat enterocytesAmerican Journal of Physiology-Gastrointestinal and Liver Physiology, 2003
- Identification of hypoxia‐responsive messengers expressed in human microvascular endothelial cells using differential display RT‐PCREuropean Journal of Biochemistry, 2000